298380 — ABL Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for ABL Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	70,391	43,647	78,309	71,150	140,660
Net Total Accounts Receivable
Net Total Receivables	1,394	208	573	2,003	1,223
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71,920	45,472	80,535	75,539	144,151
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,065	3,304	6,713	76,035	85,406
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	99,894	65,453	185,181	160,144	231,976
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,969	8,750	72,172	41,760	63,361
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	9,230	9,500	115,667	86,065	64,696
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	90,665	55,953	69,513	74,079	167,280
Total Liabilities & Shareholders' Equity	99,894	65,453	185,181	160,144	231,976
Total Common Shares Outstanding
Total Preferred Shares Outstanding